Carl Icahn
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
View Older Stories View More Recent Stories
-
Lionsgate (LGF) Responds to Icahn Letter; Says Bid Woefully Inadequate; Highlights Company Achievements
-
Icahn Reponds to Lions Gate (LGF) CEO on Rejection of Offer
-
Lions Gate (LGF) Tells Icahn to Get Lost
-
Notable Mergers and Acquisitions of the Day 03/23: TGI, PRGO, LGF, TWX (SNE)
-
Lionsgate (LGF) Calls Carl Icahn Offer "Inadequate and Coercive"
-
Lions Gate Entertainment (LGF) rejects Carl Icahn's unsolicited tender offer
-
Icahn Gets Another Seat on Biogen (BIIB) Board
-
Icahn Buys 710K More Shares of Take-Two (TTWO); Stake Now at ~14%
-
Biogen (BIIB) Appoint Dr.'s Eric Rowinsky and Stephen Sherwin to Board
-
Federal-Mogul (FDML) CEO Alapont Extends Employment Agreement Through 2013
-
Icahn Now Wants "All" of Lions Gate (LGF)
-
Notable Mergers and Acquisitions of the Day 03/19: LGF, MORN, DMND
-
Icahn Announces Intent to Purchase All Shares of Lions Gate (LGF)
-
Icahn now making offer for all Lions Gate (LGF) shares -Bloomberg
-
Joseph "Jay" Fitzsimmons Will Stand for Election to the Blockbuster (BBI) Board; Rod McDonald Appointed Company Secretary
-
Notable Mergers and Acquisitions of the Day 03/12: CF/ TRA, LGF, EXFO
-
Lionsgate (LGF) Shareholders See Icahn Bid Inadequate
-
Biogen Idec (BIIB) Up On Renewed Takeover Speculation
-
Icahn Enterprises, L.P. (IEP) Posts Narrower Loss of $0.09 for Q4; Revs Better Y/Y
-
Take-Two (TTWO) Shares Quiet Ahead of Today's Q1 Results
-
Lionsgate (LGF) Receives Offer from Carl Icahn; 13.16M Common for $6/Share Cash
-
Icahn Seeks To Shake-Up Genzyme's (GENZ) Board
-
Genzyme (GENZ) Receives Notice of Icahn Partners' Nomination
-
Icahn Enterprises (IEP) Retracts Pay-In-Kind Redemption Notice
-
Icahn Signs Deal to Purchase Fontainebleau Resort for $156.1M
-
Icahn Offers $6/Share To Acquire 29.9% of Lions Gate (LGF), Seeks To Thwart Co. From Entering Non-Core Transaction
-
Lions Gate (LGF) Surges 6% as Icahn Offers to Buy ~13M Shares at $6/Share
-
Carl Icahn announces a tender offer for shares of Lions Gate (LGF) at $6/share
-
Carl Icahn Raises Stakes In Take-Two (TTWO) and Genzyme (GENZ), Slashes Stake in Yahoo! (YHOO)
-
Motorola (MOT) Plans to Split the Company into Two in Early 2011
-
Take-Two (TTWO) volatility low at 54
-
Icahn Boosts Stake in Take-Two (TTWO) to 12.3%
-
Icahn Plans to Nominate Three To Biogen Idec (BIIB) Board
-
Forest Labs (FRX) Developing Drugs, and Potential Profits, for Investors - Barron's
-
Standpoint Research Initiates Coverage on Biogen Idec (BIIB) with a Buy
-
Genzyme (GENZ) Not in Talks With Icahn - DJN
-
Activist investor Carl Icahn may launch proxy battle at Genzyme Corp (GENZ) - Reuters
-
Icahn Enterprises (IEP) Plans to Offer $2B in New Debt
-
Take-Two Interactive (TTWO) Options Limited Going Into FY10 - Barron's
-
Take-Two (TTWO) Jan volatility elevated at 69, February at 64
-
Icahn Discloses 11.3% Stake in Take-Two (TTWO), Says Shares Undervalued
-
Icahn Outbids Penn National Gaming (PENN) On Bankrupt Fontainebleau Casino Project
-
Carl Icahn Takes a Stab At Beaten-Up Genzyme (GENZ), Can He Spark a Rally
-
Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
-
David Faber expects CIT (CIT) will still file prepackaged bankruptcy by Monday, even after Icahn deal - CNBC
-
CIT Group (CIT) Enters Agreement With Carl Icahn, Obtains $1B Line of Credit
-
CIT, Icahn reach a tentative deal on restructuring. Icahn will provide a $1 billion backup line to CIT - wsj
-
Unusual 11 Mid-Day Movers 10/28: CTS, QTM, KWR, CIT, NTRI Higher; KSP, CALC, PSYS, ILMN Lower
-
CIT Jumps 12% on Financing News
-
CIT gets added $4.5B in financing from lenders, not from Icahn
